Active Monitoring of the Comparative Effectiveness and Safety of Prasugrel vs. Clopidogrel in Routine Care

被引:0
|
作者
Gagne, Joshua J. [1 ,2 ]
Rassen, Jeremy A. [1 ,2 ]
Choudhry, Niteesh K. [1 ,2 ]
Bohn, Rhonda L. [3 ]
Patrick, Amanda R. [1 ,2 ]
Sridhar, Gayathri [4 ]
Liu, Jun [1 ,2 ]
Schneeweiss, Sebastian [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Rhonda L Bohn LLC, Waban, MA USA
[4] HealthCore Inc, Govt & Acad Res, Wilmington, DE USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
508
引用
收藏
页码:238 / 239
页数:2
相关论文
共 50 条
  • [41] In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding
    Elgendy, Islam Y.
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (06) : JC27 - JC27
  • [42] Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation
    Blin, Patrick
    Dureau-Pournin, Caroline
    Cottin, Yves
    Benichou, Jacques
    Mismetti, Patrick
    Abouelfath, Abdelilah
    Lassalle, Regis
    Droz, Cecile
    Moore, Nicholas
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (06) : 1439 - 1455
  • [43] Comparative Effectiveness and Safety of Extended Treatment vs. Discontinuation of Oral Anticoagulants in Patients with Venous Thromboembolism
    Lin, Kueiyu Joshua
    Kim, Dae Hyun
    Singer, Daniel E.
    Zhang, Yichi
    Cervone, Alexander
    Bykov, Katsiaryna
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 102 - 102
  • [44] Safety and Effectiveness of Dabigatran Relative to Warfarin in Routine Care
    Seeger, John D.
    Bartels, Dorothee B.
    Huybrechts, Krista
    Bykov, Katsiaryna
    Shash, Dalia
    Zint, Kristina
    Schneeweiss, Sebastian
    CIRCULATION, 2014, 130
  • [45] Effectiveness and safety of phentolamine mesylate in routine dental care
    Daublaender, Monika
    Liebaug, Frank
    Niedeggen, Gabriele
    Theobald, Karlheinz
    Kuerzinger, Marie-Laure
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2017, 148 (03): : 149 - 156
  • [46] Comparative effectiveness of NALIRIFOX vs. FOLFIRINOX in pancreatic cancer
    Jiao, Xiayu
    Barzi, Afsaneh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Comparative Cardiovascular Safety and Effectiveness of Linagliptin in Routine Care: Final Results from a 5-Year Post-Marketing Monitoring Program
    Patorno, Elisabetta
    Gopalakrishnan, Chandrasekar
    Mahesri, Mufaddal
    Brodovicz, Kimberly G.
    Bartels, Dorothee
    Meyers, Andrea
    Barberio, Julie
    Liu, Jun
    Schneeweiss, Sebastian
    DIABETES, 2019, 68
  • [48] Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry
    Riedmaier, P.
    Hochadel, M.
    Ince, H.
    Darius, H.
    Hoffmeister, T.
    Zahn, R.
    Zeymer, U.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1263 - 1263
  • [49] Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry
    Zeymer, U.
    Hochadel, M.
    Schaechinger, V.
    Zahn, R.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1388 - 1388
  • [50] The comparison of clopidogrel effectiveness in patients with hemodynamically stable vs. unstable acute myocardial infarction
    Osmancik, P. P.
    Jirmar, R.
    Hulikova, K.
    Peroutka, Z.
    Bednar, F.
    Widimsky, P.
    EUROPEAN HEART JOURNAL, 2008, 29 : 329 - 329